(c) 2024 PillSync.com

efavirenz emtricitabine and tenofovir disoproxil fumarate 600 mg

1 INDICATIONS AND USAGE Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablets are indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablets are a three-drug combination of efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor, and emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF), both HIV-1 nucleoside analog reverse transcriptase inhibitors, and is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. ( 1 )

Camber Pharmaceuticals, Inc.


5 months ago OVAL WHITE H 128 efavirenz emtricitabine and tenofovir disoproxil fumarate 600 mg

OVAL WHITE H 128

5 months ago OVAL WHITE H 128 efavirenz emtricitabine and tenofovir disoproxil fumarate 600 mg

H 128 OVAL WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING

EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets 600 mg/200 mg/300 mg are white to off-white colored, capsule shaped, film-coated tablets debossed with ‘H’ on one side and ‘128’ on the other side. Each bottle contains 30 tablets (NDC 31722-736-30) and silica gel desiccant, and is closed with a child-resistant closure. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. • Keep container tightly closed. • Dispense only in original container.


More pills like OVAL H 128

Related Pills












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site